Find and Pitch Jounalists, Get Your Story Covered

Tags: Bispecific Antibodies cytokine release syndrome immune effector cell–associated neurotoxicity syndrome Bispecific Treatments Diffuse Large B Cell Lymphoma

	Profile	Recent Articles on Subject
1	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 8 days ago
2	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Resources and Education for Operationalizing Bispecifics - 12 days ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 19 days ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 26 days ago Current Landscape of Bispecific Therapies for RRMM - 26 days ago Alternative Treatments for eBC and mBC - 6 months ago Considerations for Maintenance Therapy in the Community Oncology Setting - 7 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	FDA Approves Zanidatamab for Biliary Tract Cancer - 30 days ago Year in Review: Follicular Lymphoma - about 1 year ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 30 days ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 9 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Breakthrough Therapy Designation for Nipocalimab to Treat Sjögren Disease - about 1 month ago Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 4 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 6 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 10 months ago FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B - 10 months ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - 11 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 12 months ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - about 1 year ago Key Market Trends for the Current Specialty Drug Pipeline - about 1 year ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - about 2 months ago Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - 2 months ago Addressing Challenges When Implementing Bispecific Antibodies in Diverse Settings - 6 months ago Addressing the Challenges of Implementing Bispecific Antibodies in Health Care Centers - 9 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 9 months ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 9 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease - 4 months ago
8	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Approves Expanded Indications for Spesolimab-sbzo Injection for the Treatment of Generalized Pustular Psoriasis - 9 months ago FDA Accepts BLA for Datopotamab Deruxtecan for the Treatment of NSCLC - 10 months ago
9	Ryan Haumschild Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody - 11 months ago
10	Erin Hunter, Assistant Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	More than 80% of Patients with Diffuse Large B-cell Lymphoma Responded to Novel Therapeutic, according to the Results of a Preclinical Trial - 12 months ago Trial-In-Progress Looks to Prophylactic Tocilizumab to Reduce CRS in Patients with Multiple Myeloma - about 1 year ago

Journalists covering Bispecific Treatments